ArriVent BioPharma, Inc. (AVBP)
NASDAQ·Healthcare·Biotechnology
$30.40
+0.20%
Mkt Cap $1.29B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
Implied Upside
+48.0%
Consensus $45.00 vs current $30.40
NASDAQ·Healthcare·Biotechnology
$30.40
+0.20%
Mkt Cap $1.29B
Buy
7
Hold
0
Sell
0
Price Target (8 analysts)
$45.00
Range $45.00 – $45.00
+48.0%
Consensus $45.00 vs current $30.40